Pressure BioSciences Announces First Manufacturing Build Completely Sold Out for Revolutionary UST System for Processing Hemp-Derived Cannabinoid Oil into Stable, Water-Soluble Nanoemulsions

$2.4 Million in Orders Received for 12 BaroShear K45 Systems to Be Built in Initial Manufacturing Run South Easton, MA – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and…
Read more

Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses with Systemic Pelareorep Treatment

Recently announced clinical data demonstrate pelareorep-induced priming of an adaptive immune response Pro-inflammatory effects of pelareorep observed across multiple breast cancer subtypes Data support further clinical development of pelareorep-anti-PD-L1 combination therapies San Diego, CA and Calgary, AB — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today provided a recap of a Key Opinion Leader (KOL)…
Read more